Effect of Sulindac and Erlotinib vs Placebo for Colorectal Neoplasia in Familial Adenomatous Polyposis

This secondary analysis of data from the the FAP Erlotinib-Sulindac Trial (FAPEST) trial examines the effect of sulindac and erlotinib on colorectal adenoma formation and regression in patients with familial adenomatous polyposis.

http://ift.tt/2nU5KNR